Bexagliflozin
Overview
Bexagliflozin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1808388).
API suppliers (1)
Suppliers of Bexagliflozin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 1 holds a GMP certificate on record in the EU or UK registers
- Piramal Pharma LimitedIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Bexagliflozin expires 5 Oct 2041 and exclusivity 20 Jan 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
- Canonical SMILES
- C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
- InChIKey
- BTCRKOKVYTVOLU-SJSRKZJXSA-N
Do you supply Bexagliflozin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.